Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations.

Invest Ophthalmol Vis Sci 2019 Jun;60(7):2474-2480

Department of Ophthalmology, the Ohio State University, Columbus, Ohio, Unites States.

Purpose: The activation of the mitogen-activated protein kinase (MAPK) pathway has been suggested as the major downstream target when GNAQ and GNA11 (GNAQ/11) are mutated in uveal melanoma (UM). However, clinical trials with single agent MEK inhibitor showed no clinical significance in altering the overall outcome of the disease in UM; therefore, we investigated the correlation between naturally occurring mutations in GNAQ/11 and activation of MAPK pathway in vivo in primary UM.

Methods: Screening for activating mutations in codons 183 and 209 of GNAQ/11 was carried out by sequencing and restriction fragment length polymorphism (RFLP) in a cohort of 42 primary UM. Activation of the MAPK pathway and other potential downstream signals was assessed by immunohistochemistry and/or Western blot analysis. Potential downstream signaling of mutant and wild type GNAQ/11 was studied by transient transfection assay in nonmutant cell lines.

Results: Somatic mutations in GNAQ/11 were observed in 35/42 (83.3%) of primary UM. Tumors with GNAQ/11 mutations showed variations in the activation of ERK1/2 with significant tumor heterogeneity. Weak and undetectable ERK1/2 activation was observed in 4/35 (11.4%) and 8/35 (22.9%) of the GNAQ/11 mutant UM, respectively. Tumor heterogeneity of GNAQ/11 mutations was also observed in a subset of tumors.

Conclusions: Our results indicate that there is marked variation in MAPK activation in UM with GNAQ/11 mutations. Thus, GNAQ/11 mutational status is not a sufficient biomarker to adequately predict UM patient responses to single-agent selective MEK inhibitor therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.18-26452DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557618PMC
June 2019
6 Reads

Publication Analysis

Top Keywords

mapk pathway
16
gnaq/11 mutations
12
mutations gnaq/11
12
gnaq/11
10
gnaq gna11
8
uveal melanoma
8
mek inhibitor
8
tumor heterogeneity
8
activation mapk
8
potential downstream
8
kinase mapk
8
protein kinase
8
mitogen-activated protein
8
mutations
7
activation
7
mapk
5
downstream signals
4
primary activation
4
pathway potential
4
subset tumorsconclusions
4

Similar Publications